Jazz Pharmaceuticals plc — Director's Dealing 2020

Feb 26, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2020-02-24

Reporting Person: COZADD BRUCE C (Director, Chairman & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-24	Ordinary Shares	M	6895	$11.48	Acquired	305783	Direct
2020-02-25	Ordinary Shares	F	2679	$127.25	Disposed	303104	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-24	Incentive Stock Option (right to buy)	$11.48	M	6895	Disposed	2020-03-07	Ordinary Shares (6895)	Direct

Footnotes

F1: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

F2: The ordinary shares subject to the option award vested over 4 years from the vesting commencement date of March 8, 2010, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of March 8, 2014.